Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.
8+Product Categories
500+Product Variants
MultipleDosage Forms
GMPQuality Sourced
Sterile injectable formulations for institutional and hospital requirements.
Beta-Lactam and Non-Beta-Lactam formulations across therapeutic categories.
Hard-shell capsule formulations in multiple strengths and compositions.
Paediatric and adult oral liquid and dry-syrup formulation options.
Creams, ointments and other topical dosage-form requirements.
Formulations supporting diabetes-management sourcing requirements.
Cardiovascular formulations across common dosage forms and strengths.
Page 2 of 4
Tablet
Glimepiride Img Tab. (Uncoated) is a tablet formulated with Glimepiride Img . ( ). The listed active ingredient profile is Glimepiride Img, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering m
Bilayered Tablet
Glimepiride IP 0.5 mg + Metformin Hydrochloride 500 mg (Uncoated bilayered Tablet) is a bilayered tablet formulated with Glimepiride IP 0.5 mg + Metformin Hydrochloride 500 mg ( ). The listed active ingredient profile is Glimepiride; Metformin Hydrochlori
Bilayered Tablet
Glimepiride lmg, Metformin Hcl (Sustained Released) 50mg + Voglibose 0.2mg Tablets (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride lmg, Metformin Hcl (Sustained Released) 50mg + Voglibose 0.2mg ( ). The listed active ingredient prof
Bilayered Tablet
Glimepiride lP 4 mg + Metformin IP 1000 mg (Uncoated bilayered Tablet) is a bilayered tablet formulated with Glimepiride lP 4 mg + Metformin IP 1000 mg ( ). The listed active ingredient profile is Glimepiride lP; Metformin, placing the product in the oral
Tablet
Glimepirlde 3mg + Metformin Hydrochloride (SR ) 500mg is a tablet formulated with Glimepirlde 3mg + Metformin Hydrochloride (SR ) 500mg. The listed active ingredient profile is Glimepirlde; Metformin Hydrochloride, placing the product in the oral antidiab
Tablet
Glipizide 5 mg + Metformin 500 mg Tablets (Uncoated Tab) is a tablet formulated with Glipizide 5 mg + Metformin 500 mg ( ). The listed active ingredient profile is Glipizide; Metformin, placing the product in the oral antidiabetic category. The formulatio
Tablet
Gllbenclamide 5mg, Mettorrmin Hydrochloride 500mg + Piogltazone Hydrochloride 15mg Tablet (ilm coated) is a tablet formulated with Gllbenclamide 5mg, Mettorrmin Hydrochloride 500mg + Piogltazone Hydrochloride 15mg (ilm coated). The listed active ingredien
Tablet
Ivabradine Hydrochloride 5mg Tab. (Film Coated) is a tablet formulated with Ivabradine Hydrochloride 5mg . ( ). The listed active ingredient profile is Ivabradine Hydrochloride, placing the product in the antianginal / cardiovascular category. The active
Tablet
Labetalol 100mg Tablets (Film coated) is a tablet formulated with Labetalol 100mg ( ). The listed active ingredient profile is Labetalol, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardiovas
Tablet
Metformin 500mg Tab. (Uncoated) is a tablet formulated with Metformin 500mg . ( ). The listed active ingredient profile is Metformin, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering medicin
Tablet
Metformin HCI (SR) 500mg is a tablet formulated with Metformin HCI (SR) 500mg. The listed active ingredient profile is Metformin HCI, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering medicin
Tablet
Metformin Hydrochloride(as Prolonged Release Form ) 1000mg + Glimepiride 0.5mg is a tablet formulated with Metformin Hydrochloride(as Form ) 1000mg + Glimepiride 0.5mg. The listed active ingredient profile is Metformin Hydrochloride; Glimepiride, placing
Tablet
Metoprolol Succinate 50 mg(ER) + Telmisartan 40mg Tab. (Film Coated) is a tablet formulated with Metoprolol Succinate 50 mg(ER) + Telmisartan 40mg . ( ). The listed active ingredient profile is Metoprolol Succinate; Telmisartan, placing the product in the
Tablet
Metoprolol Succinate Prolonged Release Tablets IP 47.5 mg is a tablet formulated with Metoprolol Succinate IP 47.5 mg. The listed active ingredient profile is Metoprolol Succinate, placing the product in the antihypertensive / cardiovascular category. The
Tablet
Nebivolol 2.5mg + Cilnidipine 10mg Tablets (Film coated bilyered) is a tablet formulated with Nebivolol 2.5mg + Cilnidipine 10mg ( bilyered). The listed active ingredient profile is Nebivolol; Cilnidipine, placing the product in the antihypertensive / car
Tablet
Nebivolol Tablets IP 2.5MG (Uncoated) is a tablet formulated with Nebivolol IP 2.5MG ( ). The listed active ingredient profile is Nebivolol, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardio
Tablet
Olmesartan 20mg + Hydrochlorothiazide 12.5 Tab. (Film Coated) is a tablet formulated with Olmesartan 20mg + Hydrochlorothiazide 12.5 . ( ). The listed active ingredient profile is Olmesartan; Hydrochlorothiazide, placing the product in the antihypertensiv
Tablet
Olmesartan 40mg Tab. (Film Coated) is a tablet formulated with Olmesartan 40mg . ( ). The listed active ingredient profile is Olmesartan, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardiovas
Tablet
Olmesartan Medoxomil 20mg + Amlodipine Besylate 5mg Tab. (Film Coated) is a tablet formulated with Olmesartan Medoxomil 20mg + Amlodipine Besylate 5mg . ( ). The listed active ingredient profile is Olmesartan Medoxomil; Amlodipine Besylate, placing the pr
Tablet
Olmesartan Medoxomil 40mg + Hydrochlorothiazide 12.5mg Tab. (Filrn Coated) is a tablet formulated with Olmesartan Medoxomil 40mg + Hydrochlorothiazide 12.5mg . (Filrn Coated). The listed active ingredient profile is Olmesartan Medoxomil; Hydrochlorothiazi
Tablet
Olmesartan Medoxomil 40mg + Hydrochlorothiazide 25mg Tab. (Film Coated) is a tablet formulated with Olmesartan Medoxomil 40mg + Hydrochlorothiazide 25mg . ( ). The listed active ingredient profile is Olmesartan Medoxomil; Hydrochlorothiazide, placing the
Tablet
Olmesartan Medoxomil 40mg + Ramipril 5mg Tab. (Film Coated) is a tablet formulated with Olmesartan Medoxomil 40mg + Ramipril 5mg . ( ). The listed active ingredient profile is Olmesartan Medoxomil; Ramipril, placing the product in the antihypertensive / c
Tablet
Ramipril 2.5 mg Tab. Uncoated) is a tablet formulated with Ramipril 2.5 mg . ). The listed active ingredient profile is Ramipril . ), placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardiovascula
Tablet
Rivaroxaban 2.5mg Tablet (film coated) is a tablet formulated with Rivaroxaban 2.5mg ( ). The listed active ingredient profile is Rivaroxaban, placing the product in the anticoagulant category. The active medicine reduces blood-clot formation through anti
Tablet
Rosuvastatin 10 mg + Fenofibrate Tablets 160mg is a tablet formulated with Rosuvastatin 10 mg + Fenofibrate 160mg. The listed active ingredient profile is Rosuvastatin; Fenofibrate, placing the product in the lipid-lowering therapy category. The formulati
GMP Certified Manufacturers
Wide Product Portfolio
Multiple Dosage Forms
Global Supply Network
Regulatory Documentation
Competitive PricingOur sourcing experts are ready to help with custom requirements, supply availability and regulatory documentation.
